mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.006 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
-0.093 |
0.006 |
mRNA |
MS-275 |
FIMM |
pan-cancer |
AAC |
0.34 |
0.007 |
mRNA |
TAE684 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.007 |
mRNA |
AZD7762 |
GDSC1000 |
pan-cancer |
AAC |
-0.088 |
0.007 |
mRNA |
AMG-706 |
FIMM |
pan-cancer |
AAC |
0.41 |
0.008 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.009 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.01 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
JQ-1 |
GDSC1000 |
pan-cancer |
AAC |
0.081 |
0.01 |